Natera (NTRA) announced a new collaboration with NVIDIA (NVDA) to accelerate the development of Natera’s multimodal AI foundation model platform and expand applications across precision medicine. Under the collaboration, Natera will integrate its unique longitudinal and multi-time point in vivo datasets and proprietary machine learning models with NVIDIA’s high-performance computing platforms, accelerated libraries, and AI frameworks. Together, the companies aim to establish the computational infrastructure required to train and deploy large scale AI models on complex medical datasets, enabling more precise diagnostics, deeper biological insight, and new tools to support personalized therapeutic decisions. Natera will utilize several NVIDIA platforms under the collaboration, including: NVIDIA Parabricks for accelerating bioinformatics workflows; NVIDIA BioNeMo for optimizing large-scale model training; and NVIDIA NeMo Agent Toolkit for building multi-agent AI systems designed for clinical and research use. Early engineering milestones show an average reduction of 75.7% in running time and 59.2% in cost using Parabricks for genomic analysis, and 45.5% gains in training speed by integrating NVIDIA Transformer Engine.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVDA:
- NVDA vs. TSLA? One Mag 7 Stock Looks Set to Win 2026
- Digi Power X secures $20M Nvidia B300 GPU purchase
- Top Analysts Recommend Buying Nvidia Stock (NVDA), See Strong Upside in 2026
- The VanEck Semiconductor ETF (SMH) News: Weekly Fund Flow Statistics – 1/12/26
- Notable open interest changes for January 12th
